PPIs, Clostridium difficile, and Bone Fractures

July 2010
Internal Medicine Alert;7/15/2010 Supplement, p1
The July 2010 issue of the publication "Pharmacology Watch" is presented, which discusses chronic proton pump inhibitors (PPIs) that can cause infections, a study on the comparison of thiazolidinedione pioglitazone and vitamin E, and the approval of the U.S. Food & Drug Administration (FDA) to the formulation of oxycodone.


Related Articles

  • The Downside of Tear Preservatives. Abelson, Mark B.; Washburn, Susan // Review of Ophthalmology;May2002, Vol. 9 Issue 5, p102 

    Focuses on the preservatives commonly used in ocular preparations. Disruption of glycocalyx; Mandates of the U.S. Food and Drug Association on preservative use; Prevention of decomposition of active drugs.

  • FDA Drug Approvals.  // Formulary;Dec2000, Vol. 35 Issue 12, p936 

    Lists several drugs approved for release by the United States Food and Drug Administration as of December 2000. Altace (ramipril) for the prevention of major cardiovascular events in high-risk patients; Novantrone (mitoxantrone) for the treatment of multiple sclerosis; Lunelle...

  • Further Action on Petition to FDA on Pediatric Rule.  // Consumer Comments;Mar/Apr2000, Vol. 24 Issue 2, p1 

    Provides information on the petition filed with the United States Food and Drug Administration, regarding the Pediatric Rule, which governs the labeling of drugs for children.

  • Pharmacovigilance & Regulatory News.  // Reactions Weekly;2/6/2010, Issue 1287, p3 

    This section offers news briefs related to pharmacology in the U.S. including the move of the Food and Drug Administration (FDA) and Lilly to notify healthcare professionals on the changes in the prescribing information for Zyprexa and the revision of the label for Velcade by Takeda Oncology.

  • Pharmacovigilance & Regulatory News.  // Reactions Weekly;6/26/2010, Issue 1307, p3 

    This section offers news briefs related to pharmacology as of June 2010, including one on the warning of the U.S. Food and Drug Administration (FDA) about the use of infants' liquid vitamin D supplement products and another on the potential effect of the product labeled as Generic Tamiflu being...

  • FDA launches new initiative to battle counterfeit drugs. Young, Donna // American Journal of Health-System Pharmacy;9/1/2003, Vol. 60 Issue 17, p1712 

    Focuses on efforts of U.S. Food and Drug Administration to stop counterfeit drug products form entering the supply chain. Creation of a task force to strengthen the pharmaceutical distribution system; Means through which counterfeit drug products enter the distribution chain; Possible...

  • Drug Evaluation After Marketing. Slone, Dennis; Shapiro, Samuel; Miettinen, Olli S.; Finkle, William D.; Stolley, Paul D. // Annals of Internal Medicine;Feb79, Vol. 90 Issue 2, p257 

    Identifies the central issues pertinent to a national system for the evaluation of drugs for both safety and efficacy after marketing as a basis for formulating policy. Reasons why the U.S. Food and Drug Administration has incomplete knowledge of the drugs' side-effects; Surveillance of newly...

  • Access to investigational drugs for treatment purposes. Nightingale, Stuart L.; Kimbrough, Carol A. // American Family Physician;9/15/1994, Vol. 50 Issue 4, p845 

    Explains the mechanisms developed by the US Food and Drug Administration (FDA) for gaining access to experimental substances for treatment purposes. Details on Treatment Investigational New Drug (IND) program; Investigational drugs under programs for specific conditions.

  • A dose of trouble. Rock, Andrea // Money;Dec1998, Vol. 27 Issue 12, p122 

    Discusses the safety of new drugs that are coming on the market and whether they are being tested adequately before their approval. How Pondimin and Redux were taken off the market; Number of drugs that came on the market in 1996 and 1997; Reduction in the amount of time it takes a drug to be...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics